KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation and Depletion: 2009-2024

Historic Depreciation and Depletion for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $1.4 million.

  • Arbutus Biopharma's Depreciation and Depletion fell 6.88% to $474,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.8 million, marking a year-over-year decrease of 10.00%. This contributed to the annual value of $1.4 million for FY2024, which is 0.28% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Depreciation and Depletion of $1.4 million as of FY2024, which was down 0.28% from $1.4 million recorded in FY2023.
  • Arbutus Biopharma's 5-year Depreciation and Depletion high stood at $2.0 million for FY2020, and its period low was $1.4 million during FY2024.
  • In the last 3 years, Arbutus Biopharma's Depreciation and Depletion had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • Data for Arbutus Biopharma's Depreciation and Depletion shows a maximum YoY dropped of 20.72% (in 2022) over the last 5 years.
  • Arbutus Biopharma's Depreciation and Depletion (Yearly) stood at $2.0 million in 2020, then decreased by 10.00% to $1.8 million in 2021, then fell by 20.72% to $1.4 million in 2022, then fell by 1.61% to $1.4 million in 2023, then fell by 0.28% to $1.4 million in 2024.